Form 4 for DRIO DarioHealth Corp.
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-10 · accession 0001104659-21-125373 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-12 | 2021-10-10 | DRIO | Raphael Erez | CEO, Dir | A - Grant | $0.00 | +695 | 944.7K | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-10 | A | A | 695 | $0.00 | 944,682 | D | — | — | (F1) The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021. |